EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Clinical Respiratory Score: Diagnostic Performance for Acute Chest Syndrome in Sickle Cell Disease

Shaniqua J Anum iD, Andy C Yu, Jonathan M Flanagan iD, Danielle Guffey iD, Nicholas A Ettinger iD, Saleh Bhar iD, Julie Katkin iD, Shruti Chaturvedi iD, Gladstone Airewele, Venée N Tubman iD

Pediatric Pulmonology · 2026-07 · 61 (7)

DOI: 10.1002/ppul.71736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 15.07.2026. Verfasst von Shaniqua J Anum und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Acute Chest Syndrome, Anemia, Sickle Cell. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Hemophilia Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute chest syndrome (ACS) is a leading cause of morbidity in pediatric sickle cell disease (SCD). The Clinical Respiratory Score (CRS) is used prospectively at the bedside for ACS, whereas the NHLBI Clinical Severity Index (CSI) classifies ACS severity retrospectively. We evaluated the diagnostic performance of peak CRS to identify severe ACS.

Methods

We conducted a retrospective cohort study of patients with ACS (one admission each) aged 3–21 years at a tertiary children's hospital (2015–2021). Peak CRS was abstracted from bedside documentation; CSI (1 = mild, 2 = moderate, 3 = severe) was assigned from the chart. The primary analysis estimated sensitivity, specificity, positive/negative predictive values (PPV/NPV), and accuracy of peak CRS ≥ 4 for identifying CSI = 3, with exact 95% confidence intervals. We prespecified a CRS 0–1 subgroup to assess NPV and de‐escalation outcomes [respiratory support, transfusion, length of stay (LOS)].

Results

Among 213 patients, peak CRS ≥ 4 predicted CSI = 3 with sensitivity 1.00 (95% CI 0.863–1.000), specificity 0.888 (0.835–0.926), PPV 0.543 (0.402–0.678), NPV 1.000 (0.978–1.000), and accuracy 0.901 (0.854–0.935). No severe events occurred with CRS < 4 (95% upper bound ~1.8%). In CRS 0–1 ( n = 74), none had severe ACS (95% upper bound ~4.1%) nor required significant respiratory support; 75.7% were not transfused; and median LOS was 2.3 days (IQR 1.4–3.1).

Conclusion

Peak CRS ≥ 4 identifies a high‐risk cohort for severe ACS; CRS 0–1 identifies a low‐risk cohort requiring minimal intervention. CRS offers a bidirectional bedside tool to guide escalation and de‐escalation of care; prospective validation is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Chest SyndromeAnemia, Sickle CellHumansFemaleMaleRetrospective StudiesAdolescentChildSeverity of Illness IndexChild, PreschoolSensitivity and SpecificityPredictive Value of TestsYoung Adult

Stichwörter der Autor:innen

high‐flow nasal cannulamechanical ventilationnegative predictive valuenoninvasive ventilationsensitivity and specificity

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Texas Children's Cancer and Hematology Center, Houston, Texas, USA.
  • Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Pediatrics, Division of Pediatric Critical Care, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Division of Pediatric Critical Care, Texas Children's Hospital, Houston, Texas, USA.

ORCID-Profile: Shaniqua J Anum, Jonathan M Flanagan, Danielle Guffey, Nicholas A Ettinger, Saleh Bhar, Julie Katkin, Shruti Chaturvedi, Venée N Tubman

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Hemophilia Foundation
  • National Institutes of Health

Zitieren

APA

Anum, S. J., Yu, A. C., Flanagan, J. M., Guffey, D., Ettinger, N. A., Bhar, S., Katkin, J., Chaturvedi, S., Airewele, G., & Tubman, V. N. (2026). The Clinical Respiratory Score: Diagnostic Performance for Acute Chest Syndrome in Sickle Cell Disease. Pediatric Pulmonology, 61(7). https://doi.org/10.1002/ppul.71736

Vancouver

Anum SJ, Yu AC, Flanagan JM, Guffey D, Ettinger NA, Bhar S, et al. The Clinical Respiratory Score: Diagnostic Performance for Acute Chest Syndrome in Sickle Cell Disease. Pediatric Pulmonology. 2026;61(7). doi:10.1002/ppul.71736

BibTeX
@article{Anum2026,
  author = {Anum, Shaniqua J and Yu, Andy C and Flanagan, Jonathan M and Guffey, Danielle and Ettinger, Nicholas A and Bhar, Saleh and Katkin, Julie and Chaturvedi, Shruti and Airewele, Gladstone and Tubman, Venée N},
  title = {The Clinical Respiratory Score: Diagnostic Performance for Acute Chest Syndrome in Sickle Cell Disease},
  journal = {Pediatric Pulmonology},
  year = {2026},
  volume = {61},
  number = {7},
  doi = {10.1002/ppul.71736}
}
Kostenlos starten →